Dexmethylphenidate Hydrochloride

CAS 40431-64-9 7 FDA-DMF suppliersSmall Molecule

Overview

Dexmethylphenidate Hydrochloride is the d-threo-enantiomer of the racemic methylphenidate hydrochloride, used as a central nervous system stimulant. It is primarily indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adults.

API suppliers (8)

Suppliers of Dexmethylphenidate Hydrochloride backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • SIEGFRIED USA LLC1 active DMF
  • SIEGFRIED USA LLC1 active DMF
  • SIEGFRIED USA LLC1 active DMF
  • PURISYS LLCUnited States1 active DMF
  • CURIA MISSOURI INC1 active DMF
  • CURIA MISSOURI INC1 active DMF
  • SIEGFRIED USA LLC1 active DMF
  • CURIA MISSOURI INC1 active DMF

Therapeutic areas

Attention Deficit Hyperactivity Disorder

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.